Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLA.L Regulatory News (SLA)

  • There is currently no data for SLA

2021 Financial Reporting

9 Mar 2021 07:05

RNS Number : 5740R
Standard Life Aberdeen plc
09 March 2021
 

 

Standard Life Aberdeen plc

 

CHANGES TO FINANCIAL METRICS AND SEGMENTS USED IN EXTERNAL REPORTING

 

Standard Life Aberdeen plc (SLA) is today setting out details of changes to financial metrics and segments used in its external reporting. The business is now operating under three growth vectors of Investments, Adviser and Personal and accordingly we are changing the way we report the performance of our business.

Key aspects:

• Three growth vectors and a small corporate centre

• Recognition that associate status has changed for HDFC Life and Phoenix

• Adjusted profit will now not include the associates and joint ventures

• Adjusted operating profit will be the key performance indicator

• Adjusted EPS will continue to be based on adjusted profit, and therefore will be rebased to reflect the change in associates status and exclusion of the share of associates and joint ventures profit

• Adjusted capital generation remains unchanged

The table below sets out the impact of the revised basis:

2020

Adjusted operating profit

Adjusted profit before tax

Adjusted capital generation

IFRS profit before tax

As reported

£219m

£487m

£262m

£838m

Revised basis

£219m

£240m

£262m

£838m

 

 

 

 

2020

Adjusted diluted EPS

Diluted EPS

Adjusted diluted capital generationper share

 

As reported

18.1p

37.9p

11.7p1

 

Revised basis

8.8p

37.9p

11.7p

 

1 Not previously reported.

 

Segmental reporting

Previously, we reported our results under two segments (under IFRS 8):

· 'Asset management, platforms and wealth' comprising all wholly owned business, HDFC Asset Management our Indian asset management associate, and the Virgin Money joint venture; and

· 'Insurance associates and joint ventures' comprising our life assurance associates and joint ventures - HDFC Life, Phoenix and HASL.

Further information on this segment reporting is set out on page 129 of the Annual report and accounts 2020.

Going forwards, from half year 2021 onwards, we will report our results under the following four segments which reflect how the business is now managed and reported:

· 'Investments' - Our global asset management business which provides investment solutions for Institutional, Wholesale and Insurance clients

· 'Adviser' - Our market-leading UK financial adviser business which provides services through the Wrap and Elevate platforms to wealth managers and advisers

· 'Personal' - Our Personal business combines our financial planning business 1825, our digital direct-to-consumer services and discretionary fund management services provided by Aberdeen Standard Capital

· 'Corporate/Strategic ' - This segment mainly comprises certain corporate costs (c£15m in 2020) and businesses held for sale (Parmenion which is expected to be sold in 2021 and SL Asia which was sold in June 2020)

Set out below is the new presentation of our reportable segments and adjusted profit metric. The segments are reported to the level of adjusted operating profit in line with management reporting. The reconciliation between the current and revised basis can be found in Appendix A.

9 March 2021

Reportable segments from continuing operations

Investments

Adviser

Personal

Corporate/ strategic

Total

31 December 2020

£m

£m

£m

£m

£m

Fee based revenue

1,176

137

80

32

1,425

Adjusted operating expenses

(990)

(89)

(85)

(42)

(1,206)

Adjusted operating profit

186

48

(5)

(10)

219

Adjusted net financing costs and investment return1

21

Adjusted profit before tax

240

Tax on adjusted profit

(38)

Adjusted profit after tax

202

Adjusted for the following items

Restructuring and corporate transaction expenses

(316)

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

(1,180)

Profit on disposal of interests in associates

1,858

Change in fair value of significant listed investments

65

Other

22

Total adjusting items

449

Dividends from significant listed investments

-

Share of profit from associates and joint ventures

194

Impairment of joint ventures

(45)

Tax on adjusting items

53

Profit attributable to non-controlling interests (preference shares)

(5)

Profit for the year attributable to equity shareholders of Standard Life Aberdeen plc

848

Profit attributable to non-controlling interests

Preference shares

5

Profit for the year

853

 

1 'Capital Management' has been renamed 'Adjusted net financing costs and investment return'.

 

Enquiries:

Institutional Investors

Catherine Nash

Helen Rennardson

 

+44 (0) 7798 518 657

+44 (0) 7554 010 422

 

 

Media

Katy Hetherington 

 

+44 (0) 7841 344 374

 

Group Secretariat

Paul McKenna

 

+44 (0)131 372 0703

Standard Life Aberdeen plc's LEI Code is 0TMBS544NMO7GLCE7H90

 

 

Appendix A - Reconciliation between current and revised basis

Current basis 

Asset management associates and joint ventures

Insurance associates and joint ventures

 

 

 

 

Revised basis

£m

£m

£m

£m

Fee based revenue

1,425

-

-

1,425

Fee based revenue

Adjusted operating expenses

(1,206)

-

-

(1,206)

Adjusted operating expenses

Adjusted operating profit

219

219

Adjusted operating profit

Capital management

21

-

-

21

Adjusted net financing costs and investment return

Share of associates' and joint ventures' profit before tax

247

(44)

(203)

-

N/A

Adjusted profit before tax

487

(44)

(203)

240

Adjusted profit before tax

Tax on adjusted profit

(38)

-

-

(38)

Tax on adjusted profit

Share of associates' and joint ventures' tax expense

(38)

12

26

-

N/A

Adjusted profit after tax

411

(32)

(177)

202

Adjusted profit after tax

Adjusted for the following items

Adjusted for the following items

Restructuring and corporate transaction expenses

(355)

10

29

(316)

Restructuring and corporate transaction expenses

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

(1,287)

-

107

(1,180)

Amortisation and impairment of intangible assets acquired in business combinations and through the purchase of customer contracts

Profit on disposal of interests in associates

1,858

-

-

1,858

Profit on disposal of interests in associates

Impairment of associates and joint ventures

(45)

45

-

-

N/A

Change in fair value of significant listed investments

65

-

-

65

Change in fair value of significant listed investments

Investment return variances and economic assumption changes

46

-

(46)

-

N/A

Other

86

-

(64)

22

Other

Total adjusting items

368

55

26

449

Total adjusting items

N/A

-

-

-

-

Dividends from significant listed investments

N/A

-

42

152

194

Share of profit from associates and joint ventures

N/A

-

(45)

-

(45)

Impairment of joint ventures

Tax on adjusting items

53

-

-

53

Tax on adjusting items

Share of associates' and joint ventures' tax expense on adjusting items

21

(20)

(1)

-

N/A

Profit attributable to non-controlling interests (preference shares)

(5)

-

(5)

Profit attributable to non-controlling interests (preference shares)

Profit for the year attributable to equity shareholders of Standard Life Aberdeen plc

848

-

-

848

Profit for the year attributable to equity shareholders of Standard Life Aberdeen plc

Profit attributable to non-controlling interests

 

Profit attributable to non-controlling interests

Preference shares

5

-

5

Preference shares

Profit for the year

853

-

-

853

Profit for the year

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFVIVAIAIIL
Date   Source Headline
2nd Jul 202112:11 pmRNSForm 8.3 - UDG Healthcare plc
2nd Jul 202112:08 pmRNSForm 8.3 - Vectura Group plc
2nd Jul 202111:58 amRNSForm 8.3 - Sanne Group plc
2nd Jul 202111:49 amRNSForm 8.3 - Spire Healthcare Group plc
2nd Jul 202111:49 amRNSForm 8.3 - John Laing Group plc
2nd Jul 202111:44 amRNSForm 8.3 - Equiniti Group plc
2nd Jul 202111:42 amRNSForm 8.3 - Ultra Electronics Holdings plc
2nd Jul 202111:40 amRNSForm 8.3 - St. Modwen Properties plc
2nd Jul 202111:37 amRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 20211:06 pmRNSForm 8.3 - John Laing Group plc
1st Jul 20211:02 pmRNSForm 8.3 - Equiniti Group plc
1st Jul 202112:59 pmRNSForm 8.3 - Ultra Electronics Holdings plc
1st Jul 202112:55 pmRNSForm 8.3 - St. Modwen Properties plc
1st Jul 202112:50 pmRNSForm 8.3 - Wm Morrison Supermarkets plc
1st Jul 202112:36 pmRNSTotal Voting Rights
1st Jul 202111:45 amRNSForm 8.3 - UDG Healthcare PLC
1st Jul 202111:37 amRNSForm 8.3 - Vectura Group plc
1st Jul 202111:34 amRNSForm 8.3 - Sanne Group plc
1st Jul 202111:30 amRNSForm 8.3 - Spire Healthcare Group plc
30th Jun 202111:53 amRNSForm 8.3 - John Laing Group plc
29th Jun 202111:51 amRNSForm 8.3 - Ultra Electronics Holdings plc
29th Jun 202111:46 amRNSForm 8.3 - St. Modwen Properties plc
29th Jun 202111:44 amRNSForm 8.3 - John Laing Group plc
29th Jun 20217:05 amRNSSale of shares in HDFC Life
28th Jun 20213:12 pmRNSForm 8.3 - Ultra Electronics Holdings plc
28th Jun 202110:47 amRNSForm 8.3 - John Laing Group plc
25th Jun 20214:24 pmRNSHolding(s) in Company
25th Jun 202111:50 amRNSForm 8.3 - John Laing Group plc
24th Jun 20215:16 pmRNSHolding(s) in Company
24th Jun 202111:19 amRNSForm 8.3 - John Laing Group plc
24th Jun 202110:19 amRNSHolding(s) in Company
23rd Jun 20212:38 pmRNSForm 8.3 - John Laing Group plc
22nd Jun 202111:55 amRNSForm 8.3 - Wm Morrison Supermarkets plc
21st Jun 20215:34 pmRNSHolding(s) in Company
21st Jun 202112:07 pmRNSForm 8.3 - UDG Healthcare PLC
21st Jun 202111:57 amRNSForm 8.3 - Vectura Group plc
21st Jun 202111:56 amRNSForm 8.3 - Sanne Group plc
21st Jun 202111:55 amRNSForm 8.3 - John Laing Group plc
21st Jun 202111:53 amRNSForm 8.3 - Spire Healthcare Group plc
21st Jun 202111:52 amRNSForm 8.3 - St. Modwen Properties plc
21st Jun 202111:51 amRNSForm 8.3 - Equiniti Group plc
18th Jun 20214:00 pmRNSHolding(s) in Company
18th Jun 202110:35 amRNSForm 8.3 - Sanne Group plc
17th Jun 20214:28 pmRNSHolding(s) in Company
17th Jun 202111:02 amRNSForm 8.3 - John Laing Group plc
17th Jun 202111:00 amRNSForm 8.3 - St. Modwen Properties plc
16th Jun 202112:37 pmRNSForm 8.3 - John Laing Group plc
16th Jun 202112:36 pmRNSForm 8.3 - Spire Healthcare Group plc
16th Jun 202112:34 pmRNSForm 8.3 - Senior plc
16th Jun 202110:20 amRNSForm 8.3 - UDG Healthcare PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.